How the Insulin Delivery Devices Market Size and Growth Are Evolving: Key Insights for 2025

 

The growing prevalence of diabetes is expected to propel the growth of the insulin delivery devices market going forward. Diabetes is a chronic condition marked by high blood sugar levels caused by either inadequate insulin production from the pancreas or the body's inability to effectively utilize insulin. Diabetes rates are increasing primarily due to factors such as sedentary lifestyles, unhealthy diets, and rising obesity rates globally. Insulin delivery devices are required for diabetes to help individuals manage their blood sugar levels effectively by administering insulin in a controlled and convenient manner, thereby preventing complications and promoting health. For instance, in December 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of young people under age 20 with type 2 diabetes in the United States could increase by nearly 700% by 2060, potentially reaching 220,000 individuals. Over the same period, diagnoses of type 1 diabetes among young people could rise by as much as 65%. Therefore, the growing prevalence of diabetes is driving the growth of the insulin delivery devices market.

#Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!#
https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

#What are the key factors influencing the forecasted market size of the insulin delivery devices industry?#
The insulin delivery devices market size has grown strongly in recent years. It will grow from $17.71 billion in 2024 to $19.22 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to convenience and ease of use offered by insulin delivery devices, favorable reimbursement policies, increasing prevalence of obesity, growing aging population, increasing adoption of insulin pumps.

The insulin delivery devices market size is expected to see strong growth in the next few years. It will grow to $26.3 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing prevalence of diabetic population, increasing healthcare expenditure on diabetes care, rise of continuous glucose monitoring systems, growing awareness among patients about benefits of automated insulin delivery devices, rising focus on healthcare. Major trends in the forecast period include technological advancements in insulin delivery devices, integration of digital technology with insulin delivery devices, development of artificial pancreas systems, advancements in insulin administration technology, bionic technology advancements.

#Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!#
https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

#Who are the leading competitors in the insulin delivery devices market?#
Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

#Which emerging trends are set to transform the insulin delivery devices market landscape?#
Major companies operating in the insulin delivery devices market are developing innovative products, such as insulin pumps, to provide continuous or customizable insulin delivery. Insulin pumps are programmable medical devices that deliver insulin continuously or as needed through a catheter placed under the skin. For instance, in May 2023, Beta Bionics, a US-based medical technology company, announced U.S. Food and Drug Administration approval for the iLet ACE Pump and the iLet Dosing Decision Software. The iLet Bionic Pancreas system is designed for individuals aged six and older with type 1 diabetes, combining two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). It operates using an automated insulin dosing (AID) system driven by an adaptive closed-loop algorithm, which initially uses only the user’s body weight for setup and eliminates the need for additional insulin dosing parameters. Unlike traditional pump therapy, this system requires no manual adjustment of settings, making it easier to initiate and manage. The iLet device also introduces a meal announcement feature that simplifies mealtime insulin dosing by categorizing meals as small, medium, or large, with the algorithm learning and adapting to individual insulin requirements over time.

#How do different geographies compare in terms of market share and growth potential in the insulin delivery devices market?#
 North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

#Order Your Report Now For Swift Delivery#
https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

#Which major segments of the insulin delivery devices market are experiencing the fastest growth?#
The insulin delivery devices market covered in this report is segmented –
1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps
2) By Disease Indication: Type 1, Type 2
3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:
1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length
2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors
3) By Pen Needles: Short Pen Needles, Long Pen Needles
4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens
5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens
6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps
7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps
8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

#Purchase The Exclusive Report Now To Unlock Valuable Market Insights:#
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18642

#How is the insulin delivery devices market defined?#
Insulin delivery devices refer to medical tools designed to administer insulin into the body of a person with diabetes. These devices are crucial for managing blood glucose levels in individuals who cannot produce sufficient insulin naturally. These devices are used to manage blood sugar levels effectively, providing flexibility and convenience in insulin administration.

#About The Business Research Company:#
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

#Contact Us:#
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

#Follow Us On:#
LinkedIn: https://in.linkedin.com/company/the-business-research-company 

Comments

Post a Comment

Popular posts from this blog

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Image
  The drugs for benign prostatic hypertrophy market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, increased awareness, advancements in drug therapies, healthcare access. The drugs for benign prostatic hypertrophy market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging markets, new drug developments, increasing awareness and education, regulatory approvals. Major trends in the forecast period include minimally invasive treatments, personalized medicine, combination therapies, patient-centered care, telemedicine and digital health, research and development. #Download Your Free Sample PDF:# https://www.thebusinessresearchcompany.com/sample.a...
Read more

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Generative Artificial Intelligence (AI) In Telecom Market Industry Outlook Presents Revenue And CAGR Projections To 2030

Image
  The generative artificial intelligence (AI) in telecom market size has grown exponentially in recent years. It will grow from $0.73 billion in 2025 to $1.12 billion in 2026 at a compound annual growth rate (CAGR) of 53.4%. The growth in the historic period can be attributed to growing mobile subscriber base, increasing telecom data traffic, early adoption of AI in network management, rising demand for personalized customer experiences, expansion of cloud-based telecom solutions. The generative artificial intelligence (AI) in telecom market size is expected to see exponential growth in the next few years. It will grow to $6.16 billion in 2030 at a compound annual growth rate (CAGR) of 53.0%. The growth in the forecast period can be attributed to advancements in generative AI models, integration of AI with 5G and future networks, growth in edge computing for real-time analytics, adoption of AI for security and fraud prevention, expansion of AI-driven customer support solutions. M...
Read more